title: Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid.
abstract: Apolipoprotein E (apoE) is associated with lipoproteins in the cerebrospinal fluid (CSF). APOE4 increases and APOE2 decreases the risk for Alzheimer disease (AD) compared to the risk associated with APOE3 Because apoE4 is less efficient at cholesterol efflux than apoE2 or apoE3 in vitro, we hypothesized that APOE genotype may affect apoE particle size in vivo and that these size differences may be related to AD risk. We used nondenaturing gel electrophoresis to test for differences in the size of apoE complexes in human CSF samples of various APOE genotypes and created profiles of each sample to compare the patterns of apoE distribution. For middle-aged adults with no dementia, APOE 2.3 individuals had significantly larger apoE complexes than APOE 3.3 subjects, who had significantly larger apoE complexes than APOE 3.4 and APOE 4.4 individuals. Similarly, in an independent cohort of older adults, CSF apoE complexes of APOE4-positive individuals were smaller than those of the APOE4-negative individuals. Compared to individuals with no dementia, those with the mildest stages of dementia had similar sized CSF apoE complexes. These results identify a novel phenotypic difference in the size of CSF apoE complexes in middle age that correlate with the risk of AD later in life.
authors: From the Department of Biology (NMH, MAG); and Department of Neuroscience, Georgetown University (GWR), Washington, District of Columbia.
authors: Nicolette Mary
authors: NM
authors: Heinsinger
authors: From the Department of Biology (NMH, MAG); and Department of Neuroscience, Georgetown University (GWR), Washington, District of Columbia.
authors: Mariam Alexandra
authors: MA
authors: Gachechiladze
authors: From the Department of Biology (NMH, MAG); and Department of Neuroscience, Georgetown University (GWR), Washington, District of Columbia gwr2@georgetown.edu.
authors: G William
authors: GW
authors: Rebeck
keywords: Alzheimer disease; Cerebrospinal fluid; Clinical dementia rating; Cognitively normal; Lipoproteins; Risk factor